Annual CFI
-$138.40 M
+$10.26 M+6.90%
December 31, 2023
Summary
- As of February 12, 2025, TRDA annual cash flow from investing activities is -$138.40 million, with the most recent change of +$10.26 million (+6.90%) on December 31, 2023.
- During the last 3 years, TRDA annual CFI has fallen by -$136.08 million (-5870.45%).
- TRDA annual CFI is now -21867.46% below its all-time high of -$630.00 thousand, reached on December 31, 2019.
Performance
TRDA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$82.93 M
-$58.54 M-240.10%
September 30, 2024
Summary
- As of February 12, 2025, TRDA quarterly cash flow from investing activities is -$82.93 million, with the most recent change of -$58.54 million (-240.10%) on September 30, 2024.
- Over the past year, TRDA quarterly CFI has dropped by -$79.19 million (-2119.08%).
- TRDA quarterly CFI is now -417.16% below its all-time high of $26.15 million, reached on March 31, 2024.
Performance
TRDA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$62.12 M
-$79.19 M-463.91%
September 30, 2024
Summary
- As of February 12, 2025, TRDA TTM cash flow from investing activities is -$62.12 million, with the most recent change of -$79.19 million (-463.91%) on September 30, 2024.
- Over the past year, TRDA TTM CFI has increased by +$76.53 million (+55.20%).
- TRDA TTM CFI is now -463.91% below its all-time high of $17.07 million, reached on June 30, 2024.
Performance
TRDA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TRDA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.9% | -2119.1% | +55.2% |
| 3 y3 years | -5870.4% | -541.3% | +58.2% |
| 5 y5 years | -10000.0% | -541.3% | +58.2% |
TRDA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2921.7% | +6.9% | -417.2% | +54.3% | -463.9% | +66.5% |
| 5 y | 5-year | <-9999.0% | +6.9% | -417.2% | +54.3% | -463.9% | +66.5% |
| alltime | all time | <-9999.0% | +6.9% | -417.2% | +54.3% | -463.9% | +66.5% |
Entrada Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$82.93 M(+240.1%) | -$62.12 M(-463.9%) |
| Jun 2024 | - | -$24.38 M(-193.3%) | $17.07 M(-123.8%) |
| Mar 2024 | - | $26.15 M(+37.3%) | -$71.80 M(-48.1%) |
| Dec 2023 | -$138.40 M(-6.9%) | $19.04 M(-609.6%) | -$138.40 M(-0.2%) |
| Sep 2023 | - | -$3.74 M(-96.7%) | -$138.65 M(-4.4%) |
| Jun 2023 | - | -$113.26 M(+180.0%) | -$145.04 M(+1818.3%) |
| Mar 2023 | - | -$40.44 M(-315.2%) | -$7.56 M(-94.9%) |
| Dec 2022 | -$148.65 M | $18.79 M(-285.4%) | -$148.65 M(-11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$10.13 M(-141.8%) | -$168.76 M(+5.9%) |
| Jun 2022 | - | $24.23 M(-113.3%) | -$159.44 M(-13.9%) |
| Mar 2022 | - | -$181.53 M(>+9900.0%) | -$185.21 M(+3943.8%) |
| Dec 2021 | -$4.58 M(+97.6%) | -$1.32 M(+64.0%) | -$4.58 M(+40.6%) |
| Sep 2021 | - | -$806.00 K(-47.8%) | -$3.26 M(+32.9%) |
| Jun 2021 | - | -$1.54 M(+70.0%) | -$2.45 M(+170.0%) |
| Mar 2021 | - | -$908.00 K | -$908.00 K |
| Dec 2020 | -$2.32 M(+267.9%) | - | - |
| Dec 2019 | -$630.00 K | - | - |
FAQ
- What is Entrada Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Entrada Therapeutics?
- What is Entrada Therapeutics annual CFI year-on-year change?
- What is Entrada Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly CFI year-on-year change?
- What is Entrada Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Entrada Therapeutics?
- What is Entrada Therapeutics TTM CFI year-on-year change?
What is Entrada Therapeutics annual cash flow from investing activities?
The current annual CFI of TRDA is -$138.40 M
What is the all time high annual CFI for Entrada Therapeutics?
Entrada Therapeutics all-time high annual cash flow from investing activities is -$630.00 K
What is Entrada Therapeutics annual CFI year-on-year change?
Over the past year, TRDA annual cash flow from investing activities has changed by +$10.26 M (+6.90%)
What is Entrada Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TRDA is -$82.93 M
What is the all time high quarterly CFI for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly cash flow from investing activities is $26.15 M
What is Entrada Therapeutics quarterly CFI year-on-year change?
Over the past year, TRDA quarterly cash flow from investing activities has changed by -$79.19 M (-2119.08%)
What is Entrada Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TRDA is -$62.12 M
What is the all time high TTM CFI for Entrada Therapeutics?
Entrada Therapeutics all-time high TTM cash flow from investing activities is $17.07 M
What is Entrada Therapeutics TTM CFI year-on-year change?
Over the past year, TRDA TTM cash flow from investing activities has changed by +$76.53 M (+55.20%)